- Home
- NVCR vs ADEA Comparison
NVCR vs ADEA Comparison
Compare NVCR & ADEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCR
- ADEA
- Stock Information
- Founded
- NVCR 2000
- ADEA 1990
- Country
- NVCR Switzerland
- ADEA United States
- Employees
- NVCR N/A
- ADEA N/A
- Industry
- NVCR Medical/Dental Instruments
- ADEA Computer Software: Prepackaged Software
- Sector
- NVCR Health Care
- ADEA Technology
- Exchange
- NVCR Nasdaq
- ADEA Nasdaq
- Market Cap
- NVCR 1.9B
- ADEA 1.5B
- IPO Year
- NVCR 2015
- ADEA N/A
- Fundamental
- Price
- NVCR $17.60
- ADEA $14.74
- Analyst Decision
- NVCR Buy
- ADEA Strong Buy
- Analyst Count
- NVCR 7
- ADEA 4
- Target Price
- NVCR $32.43
- ADEA $19.50
- AVG Volume (30 Days)
- NVCR 1.4M
- ADEA 561.2K
- Earning Date
- NVCR 07-24-2025
- ADEA 08-05-2025
- Dividend Yield
- NVCR N/A
- ADEA 1.36%
- EPS Growth
- NVCR N/A
- ADEA 89.09
- EPS
- NVCR N/A
- ADEA 0.66
- Revenue
- NVCR $621,711,000.00
- ADEA $380,289,000.00
- Revenue This Year
- NVCR $5.56
- ADEA $10.68
- Revenue Next Year
- NVCR $9.19
- ADEA $4.16
- P/E Ratio
- NVCR N/A
- ADEA $22.26
- Revenue Growth
- NVCR 18.27
- ADEA 7.16
- 52 Week Low
- NVCR $14.17
- ADEA $9.68
- 52 Week High
- NVCR $34.13
- ADEA $17.46
- Technical
- Relative Strength Index (RSI)
- NVCR 49.74
- ADEA 64.05
- Support Level
- NVCR $16.81
- ADEA $14.33
- Resistance Level
- NVCR $18.59
- ADEA $14.99
- Average True Range (ATR)
- NVCR 0.74
- ADEA 0.41
- MACD
- NVCR 0.08
- ADEA 0.07
- Stochastic Oscillator
- NVCR 56.18
- ADEA 88.64
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.
About ADEA Adeia Inc.
Adeia Inc is a consumer and entertainment product/solutions licensing company. Its only operating segment being Intellectual Property (IP) Licensing. In the IP segment, it primarily license innovations to leading companies in the broader entertainment industry, and those developing new technologies that will help drive this industry forward. It includes Pay-TV, Consumer Electronics, Connected Car, and Media Platform.